United States · FDA National Drug Code directory
LOTEPREDNOL ETABONATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0574-4135_1c88bd5e-7e65-4cfe-b1d9-0894f4a4f82a
- Product NDC
- 0574-4135
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- loteprednol etabonate
- Labeler
- Padagis US LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260112
- Source listing expiry
- 20271231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (0574-4135-05) / 5 mL in 1 BOTTLE, DROPPER · 0574-4135-05
- 1 BOTTLE, DROPPER in 1 CARTON (0574-4135-10) / 10 mL in 1 BOTTLE, DROPPER · 0574-4135-10
- 1 BOTTLE, DROPPER in 1 CARTON (0574-4135-15) / 15 mL in 1 BOTTLE, DROPPER · 0574-4135-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →